CD19 and CD20 B-Cell Lymphocyte Counts (Qualitative/Quantitative Immunophenotyping)
This test evaluates the presence and proportion of CD19 and CD20 markers on B-cells in your blood, often used to assess immune cell populations or diagnose conditions like lymphoma or leukemia.
["Helps diagnose blood cancers or immune disorders by checking specific B-cell markers."]
Key facts at a glance
- LOINC
- 94689-7
- Short code
- CD20CD19
- Synonyms
- CD20 Cells/Cells.CD19 NFr Bld
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA (lavender/purple-top) blood collection tube; sodium heparin (green-top) acceptable alternative
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–120 years
- Method
- Flow cytometry using fluorochrome-conjugated monoclonal antibodies against CD20 and CD19 surface markers, with ratio calculation
- CPT
- 86355
- SNOMED
- 444100007
- Specimen volume
- 3-5 mL whole blood (minimum 1 mL for pediatric patients); 5 mL preferred for adult flow cytometry panels
- Stability
- Room temperature: 24-48 hours (process within 24 hours preferred); Refrigerated (2-8°C): up to 48 hours. Do not freeze. Viability and marker expression may decline with prolonged storage.
- Hemolysis max
- 100
- Lipemia max
- 100
- Icterus max
- 50
- TAT
- 4–24 hours
- Order
- routine
Why This Test Is Done
Doctors may order this test to diagnose or monitor conditions such as chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma, or other B-cell-related cancers. It can also help track treatment responses or rule out immune system abnormalities.
What to Expect Before the Test
No special preparation is needed. You’ll have a small needle inserted into your arm or vein to draw a blood sample. The process takes a few minutes, and you may feel a brief pinch. If you’re nervous, let your healthcare provider know.
What the Results Mean
Results show the percentage or absolute count of CD19+ and CD20+ cells in your blood. Abnormal findings may indicate an overproduction of B-cells (e.g., cancer) or other immune-related issues. Your doctor will interpret these results in the context of your symptoms and medical history.
Common Conditions This Test Helps Diagnose
This test is critical for diagnosing blood cancers like chronic lymphocytic leukemia (CLL), follicular lymphoma, and other B-cell lymphomas. It may also help identify immune disorders or monitor treatment progress in patients undergoing chemotherapy or immunotherapy.
Reference range
CD20/CD19 ratio: typically >0.95 (≥95%) in healthy individuals, as nearly all CD19+ B lymphocytes co-express CD20. Absolute CD19+ B cell counts vary by age with higher levels in children that decline to adult ranges by adolescence.N/A
No special preparation required. Patients should inform the laboratory of any recent immunomodulatory therapy including rituximab, obinutuzumab, or other anti-CD20 monoclonal antibody treatments. Recent corticosteroid use or chemotherapy may affect results.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance: How Results Guide Treatment
Short name
B-Cell Immunophenotyping (Screen/Confirm)
Frequently asked questions
How will my test results affect my treatment plan?
What if my test results are abnormal?
Can I prepare for this test differently if I’m on certain medications?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy